Durability of the neutralizing antibody response to vaccine and non-vaccine HPV types 7 years following immunization with either Cervarix® or Gardasil® vaccine. (Record no. 29531207)

MARC details
000 -LEADER
fixed length control field 01653 a2200433 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250518032003.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 202009s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 1873-2518
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1016/j.vaccine.2019.03.052
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Godi, Anna
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20200916
245 00 - TITLE STATEMENT
Title Durability of the neutralizing antibody response to vaccine and non-vaccine HPV types 7 years following immunization with either Cervarix® or Gardasil® vaccine.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Vaccine
Date of publication, distribution, etc. 04 2019
300 ## - PHYSICAL DESCRIPTION
Extent 2455-2462 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Clinical Trial, Phase IV; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Adolescent
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antibodies, Neutralizing
General subdivision blood
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antibodies, Viral
General subdivision blood
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Cross Protection
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Female
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Genotype
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Papillomaviridae
General subdivision classification
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Papillomavirus Infections
General subdivision immunology
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Papillomavirus Vaccines
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Time Factors
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Panwar, Kavita
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Haque, Mahmoud
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Cocuzza, Clementina E
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Andrews, Nick
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Southern, Jo
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Turner, Paul
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Miller, Elizabeth
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Beddows, Simon
773 0# - HOST ITEM ENTRY
Title Vaccine
Related parts vol. 37
-- no. 18
-- p. 2455-2462
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1016/j.vaccine.2019.03.052">https://doi.org/10.1016/j.vaccine.2019.03.052</a>
Public note Available from publisher's website

No items available.